Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Antineoplastic Agents | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 41. Antineoplásicos y agentes inmunomoduladores | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 17. ONCOLOGIA | No observations |
| Haiti. National List of Essential Medicines | 08.02 Cytotoxic and adjuvant drugs | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 8.2 Cytotoxics | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 08.02.03 Rituximab | No observations |
| List | Section | Observation |
|---|---|---|
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 41. Antineoplásicos y agentes inmunomoduladores | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 17. ONCOLOGIA | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 17. ONCOLOGIA | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 10.0 Antineoplastics | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 8.2 Cytotoxics | No observations |
| Haiti. National List of Essential Medicines | 08.02 Cytotoxic and adjuvant drugs | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 08.02.03 Rituximab | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies | No observations |
| Bahamas. Drug Formulary | 10. ANTINEOPLASTIC AND RELATED AGENTS | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies | No observations |
| Bahamas. Drug Formulary | 10. ANTINEOPLASTIC AND RELATED AGENTS | No observations |
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 18.01. FÁRMACOS CITOTÓXICOS | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 17. ONCOLOGIA | No observations |
| Guyana. Essential Medicines List. 2020-2021 | 9.02.07. Monoclonal Antibodies | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | L. AGENTES ANTINEOPLÁSICOS E IMUNOMODULADORES | No observations |
| El Salvador - 2019 | ANTINEOPLASICOS: Monoclonales | No observations |